Showing results (71-80 of 208) with videos related to

Sort By:
Pageof 21
Oncoimmunology|November 20, 2019
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanomaNausicaa Malissen, Nicolas Macagno, Samuel Granjeaud, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2015
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guidelineCeleste Lebbe, Jürgen C Becker, Jean-Jacques Grob, et al.
American Journal of Therapeutics|June 11, 2014
Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countriesAlberto Wainstein, Salvador Martin Algarra, Lars Bastholt, et al.
ESMO Open|November 28, 2017
Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signatureJean-Jacques Grob, Laurent Mortier, Lionel D'Hondt, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2012
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) studyJean Jacques Grob, Thomas Jouary, Brigitte Dréno, et al.
Bulletin Du Cancer|May 23, 2006
[Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)]Sylvie Négrier, Philippe Saiag, Bernard Guillot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2015
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineAlexander Stratigos, Claus Garbe, Celeste Lebbe, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): development and validation of an instrument to measure the quality of life of the caregivers of patients with cancerPatricia Minaya, Karine Baumstarck, Julie Berbis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2025
Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trialJohn M Kirkwood, Peter Mohr, Christoph Hoeller, et al.
Pageof 21